|
Ferreiro JL, Vivas D, De La Hera JM, Marcano AL, Lugo LM, Gomez-Polo JC, Silva I, Tello-Montoliu A, Marin F, Roldan I. High and low on-treatment platelet reactivity to P2Y12 inhibitors in a contemporary cohort of acute coronary syndrome patients undergoing percutaneous coronary intervention. Thromb Res. 2019 Mar;175:95-101. doi: 10.1016/j.thromres.2019.01.021. Epub 2019 Jan 31. PubMed PMID: 30738371.
AÑO: 2019; IF: 2.869
|
30738371
|
Esteve-Pastor MA, Roldan V, Rivera-Caravaca JM, Ramirez-Macias I, Lip GYH, Marin F. The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal. Thromb Haemost. 2019 Dec;119(12):1901-1919. doi: 10.1055/s-0039-1696955. Epub 2019 Sep 9. PubMed PMID: 31499565.
AÑO: 2019; IF: 4.385
|
|
Lopez-Fernandez T, Martin-Garcia A, Roldan Rabadan I, Mitroi C, Mazon Ramos P, Diez-Villanueva P, Escobar Cervantes C, Alonso Martin C, Alonso Salinas GL, Arenas M, Arrarte Esteban VI, Ayala de La Pena F, Castro Fernandez A, Garcia Pardo H, Garcia-Sanz R, Gonzalez Porras JR, Lopez de Sa E, Lozano T, Marco Vera P, Martinez Marin V, Mesa Rubio D, Montero A, Oristrell G, Perez de Prado A, Velasco Del Castillo S, Virizuela Echaburu JA, Zatarain-Nicolas E, Anguita Sanchez M, Tamargo Menendez J; Expert reviewers. Atrial Fibrillation in Active Cancer Patients: Expert Position Paper and Recommendations. Rev Esp Cardiol (Engl Ed). 2019 Sep;72(9):749-759. doi: 10.1016/j.rec.2019.03.019. Epub 2019 Aug 9. English, Spanish. PubMed PMID: 31405794.
AÑO: 2019; IF: 4.642
|
|
Anguita Sanchez M, Bertomeu Martinez V, Ruiz Ortiz M, Cequier Fillat A, Roldan Rabadan I, Muniz Garcia J, Badimon Maestro L, Esteve Pastor MA, Marin Ortuno F; FANTASIIA study investigators. Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA study. Rev Esp Cardiol (Engl Ed). 2020 Jan;73(1):14-20. doi: 10.1016/j.rec.2019.02.021. Epub 2019 May 31. English, Spanish. PubMed PMID: 31160265.
AÑO: 2020; IF: 4.753
|
|
Hernandez-Romero D, Sanchez-Quinones J, Vilchez JA, Rivera-Caravaca JM, de la Morena G, Lip GYH, Climent V, Marin F. Galectin-3 and beta-trace protein concentrations are higher in clinically unaffected patients with Fabry disease. Sci Rep. 2019 Apr 17;9(1):6235. doi: 10.1038/s41598-019-42727-4. PubMed PMID: 30996283; PubMed Central PMCID: PMC6470309.
AÑO: 2019; IF: 3.998
|